A Pilot Study of NY-ESO-1ᶜ²⁵⁹T Cells in Subjects With Advanced Myxoid/ Round Cell Liposarcoma
Phase of Trial: Phase I/II
Latest Information Update: 03 Nov 2017
At a glance
- Drugs NY-ESO-1c259 TCR-transduced lymphocytes (Primary) ; Cyclophosphamide; Fludarabine
- Indications Liposarcoma
- Focus Therapeutic Use
- Sponsors Adaptimmune
- 03 Nov 2017 According to an Adaptimmune media release, data from the study will be presented at the upcoming CTOS meeting 2017.
- 06 Jun 2017 Trial design presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
- 05 Jun 2017 According to an Adaptimmune Therapeutics media release, as of May 18, 2017, 3 subjects have been enrolled in the study.